Literature DB >> 26149213

MicroRNA-410 promotes cell proliferation by targeting BRD7 in non-small cell lung cancer.

Dengrui Li1, YongHui Yang2, GuiYun Zhu3, XinYan Liu4, Min Zhao5, XiaoXia Li3, QinOu Yang3.   

Abstract

miR-410 acts as an oncogene or tumor suppressor gene in some malignancies. However, its role in NSCLC is still unknown. In this study, we showed that the expression of miR-410 was up-regulated in both human NSCLC tissues and cells. Overexpression of miR-410 promoted cell proliferation, migration, and invasion of NSCLC. In addition, bromodomain-containing protein 7 (BRD7) was a direct target of miR-410. MiR-410-mediated downregulation of BRD7 led to increase Akt phosphorylation. Inhibition of Akt phosphorylation can rescue the effect of miR-410 on NSCLC cell. The expression of BRD7 was downregulated in NSCLC and was inversely expressed with miR-410 in NSCLC. Our data provided new knowledge regarding the role of miR-410 in the lung cancer progression.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bromodomain-containing protein 7; Non-small cell lung cancer; miR-410; microRNA

Mesh:

Substances:

Year:  2015        PMID: 26149213     DOI: 10.1016/j.febslet.2015.06.031

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.

Authors:  László Bányai; Maria Trexler; Krisztina Kerekes; Orsolya Csuka; László Patthy
Journal:  Elife       Date:  2021-01-11       Impact factor: 8.140

2.  miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma.

Authors:  Y Liu; R Zhao; H Wang; Y Luo; X Wang; W Niu; Y Zhou; Q Wen; S Fan; X Li; W Xiong; J Ma; X Li; M Tan; G Li; M Zhou
Journal:  Cell Death Dis       Date:  2016-03-24       Impact factor: 8.469

3.  LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma.

Authors:  Nan Yang; Jinqiu Chen; Hui Zhang; Xiaman Wang; Huan Yao; Yue Peng; Wanggang Zhang
Journal:  Cell Death Dis       Date:  2017-08-10       Impact factor: 8.469

Review 4.  Bromodomain inhibitors and cancer therapy: From structures to applications.

Authors:  Montserrat Pérez-Salvia; Manel Esteller
Journal:  Epigenetics       Date:  2016-12-02       Impact factor: 4.528

5.  MicroRNA-410-5p exacerbates high-fat diet-induced cardiac remodeling in mice in an endocrine fashion.

Authors:  Tong Zou; Mei Zhu; Yi-Cheng Ma; Fei Xiao; Xue Yu; Li Xu; Lan-Qing Ma; Jiefu Yang; Jian-Zeng Dong
Journal:  Sci Rep       Date:  2018-06-08       Impact factor: 4.379

6.  MicroRNA-410-3p modulates chondrocyte apoptosis and inflammation by targeting high mobility group box 1 (HMGB1) in an osteoarthritis mouse model.

Authors:  Hong Pan; Huming Dai; Linzhi Wang; Silong Lin; Yuefeng Tao; Yi Zheng; Renyi Jiang; Fan Fang; Yifan Wu
Journal:  BMC Musculoskelet Disord       Date:  2020-07-24       Impact factor: 2.362

7.  Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer.

Authors:  Xin Liu; Kent-Man Chu
Journal:  J Cell Mol Med       Date:  2020-05-08       Impact factor: 5.310

8.  IL-27 inhibits non-small-cell lung cancer cell metastasis by miR-935 in vitro.

Authors:  Tao Wang; Yifei Chen; Hanxiang Nie; Yi Huang; Yang Zhao; Jiong Yang
Journal:  Onco Targets Ther       Date:  2019-02-21       Impact factor: 4.147

9.  MicroRNA410 Inhibits Pulmonary Vascular Remodeling via Regulation of Nicotinamide Phosphoribosyltransferase.

Authors:  Hui Gao; Jiwang Chen; Tianji Chen; Yifang Wang; Yang Song; Yangbasai Dong; Shuangping Zhao; Roberto F Machado
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

10.  TRIM44, a crucial target of miR-410, functions as a potential oncogene in osteosarcoma.

Authors:  Heng Wang; Zi-Ling Fang; Gong-Hao Zhang; Xin Ma
Journal:  Onco Targets Ther       Date:  2018-06-21       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.